Nuo Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Nuo Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Nuo Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$578K, a 26.9% increase year-over-year.
  • Nuo Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$2.48M, a 28.7% increase year-over-year.
  • Nuo Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.17M, a 0.01% increase from 2022.
  • Nuo Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.17M, a 3398% decline from 2021.
  • Nuo Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$90.7K, a 0.22% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2.48M -$578K +$212K +26.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$2.69M -$540K +$332K +38.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$3.02M -$709K +$147K +17.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$3.17M -$653K +$306K +31.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-19
Q3 2023 -$3.48M -$791K +$122K +13.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$3.6M -$872K +$52.2K +5.65% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$3.65M -$856K -$480K -128% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$3.17M -$960K -$888K -1239% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-19
Q3 2022 -$2.28M -$913K -$906K -13421% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$1.38M -$924K -$918K -14016% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-20
Q1 2022 -$460K -$375K -$370K -6461% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-20
Q4 2021 -$90.7K -$71.7K +$162K +69.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$253K -$6.75K +$8.73K +56.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$262K -$6.55K +$16.4K +71.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-04
Q1 2021 -$278K -$5.72K -$187K -103% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-04
Q4 2020 -$90.9K -$234K -$292K -504% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 $201K -$15.5K +$77.1K +83.3% Jul 1, 2020 Sep 30, 2020 10-Q 2022-11-04
Q2 2020 $124K -$22.9K +$457K +95.2% Apr 1, 2020 Jun 30, 2020 10-Q 2022-11-04
Q1 2020 -$334K $181K +$861K Jan 1, 2020 Mar 31, 2020 10-Q 2022-11-04
Q4 2019 -$1.19M $57.9K -$311K -84.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-04-15
Q3 2019 -$884K -$92.6K +$557K +85.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-01-31
Q2 2019 -$1.44M -$480K +$110K +18.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-01-31
Q1 2019 -$1.55M -$680K -$9.66K -1.44% Jan 1, 2019 Mar 31, 2019 10-Q 2020-01-31
Q4 2018 -$1.54M $368K +$8.37M Oct 1, 2018 Dec 31, 2018 10-K 2019-04-16
Q3 2018 -$9.91M -$650K +$727K +52.8% Jul 1, 2018 Sep 30, 2018 10-Q 2020-01-31
Q2 2018 -$10.6M -$590K +$3.32M +84.9% Apr 1, 2018 Jun 30, 2018 10-Q 2020-01-31
Q1 2018 -$14M -$670K +$1.02M +60.4% Jan 1, 2018 Mar 31, 2018 10-Q 2020-01-31
Q4 2017 -$15M -$8M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$1.38M +$540K +28.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 -$3.91M -$2.62M -202% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$1.69M +$3.18M +65.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q3 2016 -$50.3M -$1.92M +$11.9M +86.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$62.2M -$1.29M -$425K -48.8% May 5, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$61.8M -$4.87M -$8.98M -219% Jan 1, 2016 Mar 31, 2016 10-Q 2016-10-24
Q4 2015 -$52.8M -$42.2M -$45.1M -1578% Oct 1, 2015 Dec 31, 2015 10-K 2016-10-24
Q3 2015 -$7.74M -$13.8M -$9.04M -189% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $1.31M -$870K +$10.5M +92.3% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-13
Q1 2015 -$9.14M $4.11M +$9.74M Jan 1, 2015 Mar 31, 2015 10-Q 2016-10-24
Q4 2014 -$18.9M $2.86M +$7.75M Oct 1, 2014 Dec 31, 2014 10-K 2016-10-24
Q3 2014 -$26.6M -$4.79M +$190K +3.81% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$26.8M -$11.3M -$6.28M -125% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$20.5M -$5.63M -$294K -5.51% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$20.2M -$4.9M -$1.06M -27.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$19.2M -$4.98M -$1.19M -31.4% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-12
Q2 2013 -$18M -$5.04M +$2.42M +32.4% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-08
Q1 2013 -$20.4M -$5.34M -$615K -13% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$19.8M -$3.83M -$4.73M -527% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$15.1M -$3.78M -$1.58M -71.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$13.5M -$7.46M -$6.66M -842% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$6.82M -$4.72M -$3.31M -235% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$3.51M $897K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$2.21M -$791K -55.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$791K +$1.47M +64.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$1.41M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$1.42M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$2.26M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.